Working towards a Solution to COVID-19

We at Theraphage are proud to join industry leaders in the initiative of working towards a solution to the current COVID-19 pandemic. Our team has partnered with innovative researchers from the University of Waterloo and is currently working to develop a COVID-19 vaccine that can be administered intranasally. Developmental stages will take some months, but we are confident that this vaccine has great potential and are working hard to see it through.

When complete, our DNA-based vaccine will be administered non-invasively as a nasal spray that delivers nanomedicine engineered to immunize and decrease COVID-19 infections.
— Roderick Slavcev, Co-founder and CEO of Theraphage
covid vaccine.png

You can read more about our ventures both at a press release made by the University of Waterloo as well as news coverage by CTV Kitchener.

We would also like to take a moment to thank all of the healthcare workers, grocery store clerks, sanitation workers, truck drivers, bus drivers and all other essential workers for their dedication and hard work during this trying time. To everyone staying home and adhering to the guidelines set out by health ministers and the government, we appreciate contributions to protecting the most vulnerable.

NewsFarah El-zarkout